News
Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...
This valuable study shows that locomotion-related modulations in the mouse visual cortex are not uniform but primarily affect neurons in muscarinic receptor-negative patches, which receive projections ...
A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.
There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...
6d
GlobalData on MSNPluri’s immune cell expansion technologies gain patentsBiotechnology company Pluri has announced the issuance of a patent by the US Patent and Trademark Office (USPTO) for its ...
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
6d
GlobalData on MSNSeismic Therapeutic doses healthy subject cohort in Phase I trial of S-4321Seismic Therapeutic has dosed the first healthy participant cohort in the randomised Phase I trial of bifunctional antibody S ...
The team is optimizing the cancer genome analysis system to integrate it into CRC diagnosis and tailor treatments based on genetic mutations.
Bacteriophages, or phages, viruses that selectively target and infect bacteria, have drawn growing attention for their ...
The data convincingly show that the transcription factor Sp1 regulates ephrin-mediated axon guidance in the spinal cord. Although the authors show that Sp1 and its co-activators p300 and CBP are ...
Leveraging AI, researchers have identified a naturally occurring molecule that can suppress appetite and facilitate weight loss in mice and pigs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results